n/a.

2 trials

Sponsors

UCB Pharma, Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW)

Conditions

Epilepsy seizures (attacks)Multiple sclerosis Multiple sclerosis

Unknown Phase

SINGLE CENTER, OPEN LABEL, RANDOMIZED TWO-WAY CROSSOVER STUDY OF THE EFFECT OF LACOSAMIDE 200MG TWICE DAILY ON THE SINGLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN (25 MG) IN HEALTHY MALE VOLUNTEERS

Active, not recruitingNL-OMON37817

UCB PharmaEpilepsy seizures (attacks)

Start: 2012-01-16Target: 16Updated: 2024-05-06

The significance of the cerebellum in multiple sclerosis: new dimensions in cerebellar 7T MRI

Active, not recruitingNL-OMON58189

Netherlands Institute for Neuroscience, Royal Netherlands Academy of Arts and Sciences (KNAW)Multiple sclerosis Multiple sclerosis

Start: 2025-12-01Target: 80Updated: 2025-12-15